meibomian gland dysfunction

Read more about the article Saying bye to blepharitis caused by staph, MGD, and Demodex
Cornea / EyeWorld articles / Fall 2026 / Featured on homepage

Saying bye to blepharitis caused by staph, MGD, and Demodex

Blepharitis diagnosis and treatment have shifted in recent years, from the ability to diagnose blepharitis subtypes to the ability to treat those subtypes specifically. Overall, it’s becoming a more treatable ocular surface disease, and three experts had something to say about it.

Comments Off on Saying bye to blepharitis caused by staph, MGD, and Demodex
September 29, 2026
Read more about the article EyeWorld Weekly, November 4, 2022
EyeWorld Weekly

EyeWorld Weekly, November 4, 2022

➤ Topline results from Phase 3 study of atropine for myopia progression ➤ Phase 3 results for novel glaucoma drop ➤ Positive results from two Phase 3 studies for patients with RVO ➤ Phase 3 results for cell therapy treating macular telangiectasia type 2 ➤ Single injection of investigational compound for DME improves BCVA ➤ FDA accepts BLA for ophthalmic bevacizumab ➤ Mobile phone attachment developed for ophthalmic clinical trials ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, November 4, 2022
November 4, 2022